POTASSIUM PHOSPHATES
- Product NDC
- 46287-024
- 11-digit product format
- 462870024
- Labeler code
- 46287
- Product ID
- 46287-024_994a32ae-32b1-4fbb-ac7a-ea8530e93801
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- monobasic potassium phosphate and dibasic potassium phosphate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- CMP PHARMA, INC.
- Application
- NDA212121
- Marketing category
- NDA
- Marketing start
- 2019-09-19
- Marketing end
- 0000-00-00
- Substance
- POTASSIUM PHOSPHATE, MONOBASIC; POTASSIUM PHOSPHATE, DIBASIC
- Active strength
- 175 mg/mL; mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 46287-024 | D | Discontinued by firm | 2026-08-17 | ||
| excluded package | package | 46287-024 | 46287-024-10 | D | Discontinued by firm | 2026-08-17 | |
| excluded package | package | 46287-024 | 46287-024-15 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 46287-024-15 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 46287-024-10 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 46287-024-15 | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 46287-024-10 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 46287-024-15 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 46287-024-10 | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N212121-001 | POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2019-09-19 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2019-09-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2019-09-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2019-09-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2019-09-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2019-09-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2019-09-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2019-09-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2019-09-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2019-09-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N212121-001 | POTASSIUM PHOSPHATES | 4500MG/15ML (300MG/ML);2650MG/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 3f01610625f2… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-09-19 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212121-001 | POTASSIUM PHOSPHATES | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2019-09-19 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | c0c555d07b60… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212121-001 | 10632150 | 2039-04-19 | U-2789 | Drug product | 2020-05-04 | a50c72e98297… |
FDA-Initiated Inactive NDC Indexing#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 46287-024-10 | ML - Milliliter | 46287-024 | ad89b35f-2287-4fc5-b4c3-6ea86c324c42 | 1 | 2020-03-10 |
| 46287-024-15 | ML - Milliliter | 46287-024 | 125d51a6-ba1a-4df1-b294-f396fd660157 | 1 | 2020-04-20 |
DailyMed Dashboard NDC Coverage#
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 46287-024-10 | 46287002410 | 10 VIAL, SINGLE-DOSE in 1 CARTON (46287-024-10) > 15 mL in 1 VIAL, SINGLE-DOSE | 2019-09-19 | 0000-00-00 | No | No | Current |
| 46287-024-15 | 46287002415 | 1 VIAL, SINGLE-DOSE in 1 CARTON (46287-024-15) > 15 mL in 1 VIAL, SINGLE-DOSE | 2019-09-19 | 0000-00-00 | No | No | Current |